ISTA Pharmaceuticals

From WikiMD's Wellness Encyclopedia

ISTA Pharmaceuticals was an American pharmaceutical company specializing in products for ophthalmic diseases. ISTA Pharmaceuticals was acquired by Bausch Health in 2012.

History[edit | edit source]

ISTA Pharmaceuticals was founded in 1992. The company was initially focused on developing and marketing products in the areas of allergy, inflammation, and ophthalmology. In 2000, ISTA Pharmaceuticals went public, trading on the NASDAQ stock exchange.

In 2012, ISTA Pharmaceuticals was acquired by Bausch Health (formerly known as Valeant Pharmaceuticals). The acquisition was part of Bausch Health's strategy to expand its portfolio of ophthalmology products.

Products[edit | edit source]

ISTA Pharmaceuticals developed several notable products during its operation. These include:

Acquisition by Bausch Health[edit | edit source]

In 2012, ISTA Pharmaceuticals was acquired by Bausch Health for approximately $500 million. The acquisition expanded Bausch Health's portfolio of ophthalmology products and strengthened its position in the global eye health market.

See also[edit | edit source]

References[edit | edit source]

Contributors: Prab R. Tumpati, MD